EPA-Approved SARS-CoV-2 Disinfectants
5 rows where Formulation_type contains "Electrostatic Spray" and Why_on_List_N = "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim"
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Contact_time,
Why_on_List_N
✖
- Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim · 5 ✖
ID ▼
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1092 |
6836-442 |
Safer |
Hydrogen peroxide |
DS6835 |
Arxada, LLC |
Healthcare; Institutional |
Hard Nonporous (HN) |
0.5 minutes |
Ready-to-use; Electrostatic Spray |
SARS-CoV-2 |
2021-04-13 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1449 |
87742-1 |
Safer |
Thymol |
Thymox Disinfectant Spray |
Laboratorie M2 |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact No Rinse (FCNR) |
1.0 minutes |
Ready-to-use; Electrostatic Spray |
SARS-CoV-2 |
2021-01-28 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1482 |
6836-305 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-23 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
10.0 minutes |
Dilutable; Electrostatic Spray |
SARS-CoV-2 |
2020-03-03 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1493 |
71847-6 |
Increased Risk |
Sodium dichloroisocyanurate |
Klorsept |
Medentech LTD |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable; Electrostatic Spray |
SARS-CoV-2 |
2021-01-28 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1494 |
71847-7 |
Increased Risk |
Sodium dichloroisocyanurate |
Klorkleen |
Medentech LTD |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Dilutable; Electrostatic Spray |
SARS-CoV-2 |
2021-01-28 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |